Molecular Insight Pharmaceuticals, Inc. Gets More Time To Talk To Creditors; Receives 30 Day Extension of Waiver Agreement

April 16 (Reuters) - Molecular Insight Pharmaceuticals Inc (MIPI.O) said it received a 30-day extension of its waiver agreement with its bond holders, sending its shares up as much as 6 percent in pre-market trade.